Monoamine oxidase A genotype predicts human serotonin 1A receptor availability in vivo

Journal of Neuroscience

Volumn 28, Issue 44, 2008, Pages 11354-11359

  Mickey, Brian J ^a,b   Ducci, Francesca ^c   Hodgkinson, Colin A ^c   Langenecker, Scott A ^a,b   Goldman, David ^c   Zubieta, Jon Kar ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Depression; Genetics; Human; Imaging; Monoamine oxidase; Polymorphism; Positron emission tomography; Serotonergic 1A receptor; Serotonin; Sex difference

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CARBON 11; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; SEROTONIN 1A RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING);

ADULT; ARTICLE; BODY MASS; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; IN VIVO STUDY; INSULA; MALE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONIN METABOLISM; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; TANDEM REPEAT; BRAIN STEM; CHEMISTRY; COMPARATIVE STUDY; ENZYMOLOGY; FOREBRAIN; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREDICTION AND FORECASTING; PROTEIN BINDING; SEXUAL DEVELOPMENT;

ADULT; BRAIN STEM; DEPRESSIVE DISORDER; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROSENCEPHALON; PROTEIN BINDING; RECEPTOR, SEROTONIN, 5-HT1A; SEX CHARACTERISTICS;

EID: 56149100442     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2391-08.2008     Document Type: Article

References (45)

1. Aghajanian GK, Sprouse JS, Sheldon P, Rasmussen K (1990) Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms. Ann N Y Acad Sci 600:93-103; discussion 103.
2. Arango V, Underwood MD, Gubbi AV, Mann JJ (1995) Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688:121-133.
3. Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ (2004) Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 9:386-392.
4. Cahill L (2006) Why sex matters for neuroscience. Nat Rev Neurosci 7:477-484.
5. Cidis Meltzer C, Drevets WC, Price JC, Mathis CA, Lopresti B, Greer PJ, Villemagne VL, Holt D, Mason NS, Houck PR, Reynolds CF 3rd, DeKosky ST (2001) Gender-specific aging effects on the serotonin 1A receptor. Brain Res 895:9-17.
6. Cordero ME, Valenzuela CY, Torres R, Rodriguez A (2000) Sexual dimorphism in number and proportion of neurons in the human median raphe nucleus. Brain Res Dev Brain Res 124:43-52.
7. Cordero ME, Rodriguez A, Torres R, Valenzuela CY (2001) Human raphe magnus nucleus: a morphometric golgi-cox study with emphasis on sex differences. Brain Res Dev Brain Res 131:85-92.
8. Cosgrove KP, Mazure CM, Staley JK (2007) Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 62:847- 855.
9. David SP, Murthy NV, Rabiner EA, Munafó MR, Johnstone EC, Jacob R, Walton RT, Grasby PM (2005) A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 25:2586-2590.
10. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, Nöthen MM, Maffei P, Franke P, Fritze J, Maier W, Propping P, Beckmann H, Bellodi L, Lesch KP (1999) Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624.
11. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C (1999) PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46:1375-1387.
12. Evrard A, Malagié I, Laporte AM, Boni C, Hanoun N, Trillat AC, Seif I, De Maeyer E, Gardier A, Hamon M, Adrien J (2002) Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice. Eur J Neurosci 15:841-851.
13. Fowler JS, Alia-Klein N, Kriplani A, Logan J, Williams B, Zhu W, Craig IW, Telang F, Goldstein R, Volkow ND, Vaska P, Wang GJ (2007) Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects. Biol Psychiatry 62:355-358.
14. Friston KJ, Frith CD, Liddle PF, Frackowiak RS (1991) Comparing functional (PET) images: the assessment of significant change. J Cereb Blood Flow Metab 11:690-699.
15. Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Ruan WJ, Huang B (2005) Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 66:1205-1215.
16. Grant BF, Hasin DS, Stinson FS, Dawson DA, Goldstein RB, Smith S, Huang B, Saha TD (2006) The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 67:363-374.
17. Hensler JG (2006) Serotonergic modulation of the limbic system. Neurosci Biobehav Rev 30:203-214.
18. Hwang DR, Simpson NR, Montoya J, Man JJ, Laruelle M (1999) An improved one-pot procedure for the preparation of [11C-carbonyl]-WAY100635. Nucl Med Biol 26:815-819.
19. Jönsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC (2000) A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res 34:239-244.
20. Kaye WH, Frank GK, Bailer UF, Henry SE (2005) Neurobiology of anorexia nervosa: clinical implications of alterations of the function of serotonin and other neuronal systems. Int J Eat Disord 37 [Suppl]:S15-S19; discussion S20-S21.
21. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB (1993) Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 29:85-96.
22. Lanoir J, Hilaire G, Seif I (2006) Reduced density of functional 5-HT1A receptors in the brain, medulla and spinal cord of monoamine oxidase-A knockout mouse neonates. J Comp Neurol 495:607-623.
23. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16:834-840.
24. Meltzer CC, Price JC, Mathis CA, Butters MA, Ziolko SK, Moses-Kolko E, Mazumdar S, Mulsant BH, Houck PR, Lopresti BJ, Weissfeld LA, Reynolds CF (2004) Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 29:2258-2265.
25. Meyer CR, Boes JL, Kim B, Bland PH, Zasadny KR, Kison PV, Koral K, Frey KA, Wahl RL (1997) Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal 1:195-206.
26. Meyer-Lindenberg A, Buckholtz JW, Kolachana B, R Hariri A, Pezawas L, Blasi G, Wabnitz A, Honea R, Verchinski B, Callicott JH, Egan M, Mattay V, Weinberger DR (2006) Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci U S A 103:6269-6274.
27. Miczek KA, de Almeida RM, Kravitz EA, Rissman EF, de Boer SF, Raine A (2007) Neurobiology of escalated aggression and violence. J Neurosci 27:11803-11806.
28. Moses-Kolko EL, Price JC, Thase ME, Meltzer CC, Kupfer DJ, Mathis CA, Bogers WD, Berman SR, Houck PR, Schneider TN, Drevets WC (2007) Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635. Synapse 61:523-530.
29. Nishizawa S, Benkelfat C, Young SN, Leyton M, Mzengeza S, de Montigny C, Blier P, DiksicM (1997) Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A 94:5308-5313.
30. Ortiz J, Artigas F, Gelpí E (1988) Serotonergic status in human blood. Life Sci 43:983-990.
31. Owesson CA, Hopwood SE, Callado LF, Seif I, McLaughlin DP, Stamford JA (2002) Altered presynaptic function in monoaminergic neurons of monoamine oxidase-A knockout mice. Eur J Neurosci 15:1516-1522.
32. Parsey RV, Oquendo MA, Simpson NR, Ogden RT, Van Heertum R, Arango V, Mann JJ (2002) Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res 954:173-182.
33. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ (2006a) Higher 5-HT(1A) receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31:1745-1749.
34. Parsey RV, Oquendo MA, Ogden RT, Olvet DM, Simpson N, Huang YY, Van Heertum RL, Arango V, Mann JJ (2006b) Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 59:106-113.
35. Sabol SZ, Hu S, Hamer D (1998) A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273-279.
36. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, Gunn RN, Grasby PM, Cowen PJ (2000) Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57:174-180.
37. Saura J, Bleuel Z, Ulrich J, Mendelowitsch A, Chen K, Shih JC, Malherbe P, Da Prada M, Richards JG (1996) Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry. Neuroscience 70:755-774.
38. Shih JC, Chen K, Ridd MJ (1999) Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 22:197-217.
39. Sjöberg RL, Ducci F, Barr CS, Newman TK, Dell'osso L, Virkkunen M, Goldman D (2008) A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial behavior. Neuropsychopharmacology 33:425-430.
40. Weiss LA, Abney M, Cook EH Jr, Ober C (2005) Sex-specific genetic architecture of whole blood serotonin levels. Am J Hum Genet 76:33- 41.
41. Wittchen HU, Zhao S, Kessler RC, Eaton WW (1994) DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 51:355-364.
42. Worsley KJ (1994) Local maxima and the expected euler characteristic of excursion sets of x2, F, and t fields. Adv Appl Prob 26:13-42.
43. Worsley KJ, Evans AC, Marrett S, Neelin P (1992) A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab 12:900-918.
44. Zhuang ZP, Kung MP, Kung HF (1994) Synthesis and evaluation of 4-(2′-methoxyphenyl)-1-[2′-[N-(2″-pyridinyl)-p-iodobenzamido] ethyl]-piperazine (p-MPPI): a new iodinated 5-HT1A ligand. J Med Chem 37:1406-1407.
45. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM, Meyer CR, Koeppe RA, Stohler CS (2002) μ-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci 22:5100-5107.